MyoD family inhibitor domain containing 2 (MDFIC2)

MyoD family inhibitor domain containing 2 (MDFIC2) is a predicted protein in humans that is classified as a protein-coding gene. It is thought to be involved in the negative regulation of DNA-templated transcription, regulation of the JNK cascade, and regulation of the Wnt signaling pathway, and is predicted to be active in the nucleus. No established links to specific diseases, drugs, or therapeutic mechanisms have been reported, and there is insufficient information to consider it an established therapeutic target or to describe its clinical relevance in detail[1][5]. The requested target "MyoD family inhibitor domain containing 2 (MDFIC2)" appears to be a relatively uncharacterized gene with little information in biomedical literature or target databases. Most research and functional data pertain to its paralog "MyoD family inhibitor domain containing (MDFIC)" rather than MDFIC2 itself[1][3][4]. The lack of drug interactions, biomarker information, and established disease associations indicates that MDFIC2 should not be considered an established therapeutic target and that there may be an error in considering it as such at this time[1][4][5]. MDFIC2 is a predicted human protein of unknown or little-characterized biological importance. The available evidence suggests that little is known about its function, disease roles, or relevance as a drug target. If a therapeutic target is needed for research or drug development, the closely related MDFIC (not MDFIC2) is far better characterized and may be more appropriate for consideration[4][3].

Other names

MyoD family inhibitor domain-containing protein 2MDFIC2